부산대학교 도서관

van Renterghem AWJ; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Oncode Institute, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.; Parra-Martinez M; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Oncode Institute, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.; Witsen M; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Oncode Institute, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.; Verkerk K; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Oncode Institute, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.; Steur M; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Oncode Institute, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.; Zeverijn LJ; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Oncode Institute, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.; Dijkstra KK; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Oncode Institute, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.; Akkari L; Oncode Institute, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Division of Tumor Biology and Immunology, the Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.; Voest EE; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Oncode Institute, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands. Electronic address: e.voest@nki.nl.

Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE

Verkerk K; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Haj Mohammad SF; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; Zeverijn LJ; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Geurts BS; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Spiekman IAC; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Verbeek FAJ; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Timmer H; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; van Maren MA; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; van der Noort V; Biometrics Department, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Parra-Martinez M; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Roepman P; Hartwig Medical Foundation, Amsterdam, the Netherlands.; Jansen AML; Department of Pathology, University Medical Cancer Center Utrecht, Utrecht, the Netherlands.; de Leng WWJ; Department of Pathology, University Medical Cancer Center Utrecht, Utrecht, the Netherlands.; Marchetti S; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Monkhorst K; Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Verheul HMW; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; Voest EE; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Spiekman IAC; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands.; Mehra N; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Zeverijn LJ; Department of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Geurts BS; Department of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Verkerk K; Department of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Haj Mohammad SF; Department of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; van der Noort V; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Roepman P; Hartwig Medical Foundation, Amsterdam, the Netherlands.; de Leng WWJ; Department of Pathology, University Medical Cancer Center Utrecht, Utrecht, the Netherlands.; Jansen AML; Department of Pathology, University Medical Cancer Center Utrecht, Utrecht, the Netherlands.; van de Luijtgaarden ACM; Department of Medical Oncology, Reinier de Graaf Hospital, Delft, the Netherlands.; van Voorthuizen T; Department of Medical Oncology, Rijnstate, Arnhem, the Netherlands.; Buffart TE; Department of Medical Oncology, Amsterdam University Medical Center, location VUMC, Cancer Center, Amsterdam, the Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; Voest EE; Department of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Verheul HMW; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands.

Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE

Mimpen IL; Netherlands Cancer Institute, Amsterdam, Netherlands.; Battaglia TW; Netherlands Cancer Institute, Amsterdam, Netherlands.; Parra Martinez M; Netherlands Cancer Institute, Amsterdam, Netherlands.; Toner-Bartelds C; Netherlands Cancer Institute, Amsterdam, Netherlands.; Zeverijn LJ; Netherlands Cancer Institute, Amsterdam, Netherlands.; Geurts BS; Netherlands Cancer Institute, Netherlands.; Verkerk K; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands.; Hoes LR; Netherlands Cancer Institute, Amsterdam, Netherlands.; van Renterghem AWJ; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands.; Noe M; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Baltimore, MD, United States.; Hofland I; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands.; Broeks A; Netherlands Cancer Institute, Amsterdam, Netherlands.; van der Noort V; Netherlands Cancer Institute, Amsterdam, Netherlands.; Stigter ECA; UMC Utrecht, Utrecht, Netherlands.; Gulersonmez CMC; UMC Utrecht, Utrecht, Netherlands.; Burgering BMT; University Medical Center Utrecht, Utrecht, Utrecht, Netherlands.; van Gogh M; University Medical Center Utrecht, Utrecht, Netherlands.; de Zoete MR; University Medical Center Utrecht, Utrecht, Netherlands.; Gelderblom H; Leiden University Medical Center, Leiden, Netherlands.; Dijkstra KK; Netherlands Cancer Institute, Amsterdam, Netherlands.; Wessels LFA; The Netherlands Cancer Institute, Amsterdam, NH, Netherlands.; Voest EE; Netherlands Cancer Institute, Amsterdam, Netherlands.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE

Geurts BS; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Zeverijn LJ; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; van Berge Henegouwen JM; Department of Clinical Genetics, Erasmus Medical Center, Leiden, The Netherlands.; van der Wijngaart H; Department of Medical Oncology, GROW, Maastricht University Medical Center, Maastricht, The Netherlands.; Hoes LR; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; de Wit GF; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Spiekman IA; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands.; Battaglia TW; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; van Beek DM; Hartwig Medical Foundation, Amsterdam, The Netherlands.; Roepman P; Hartwig Medical Foundation, Amsterdam, The Netherlands.; Jansen AM; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.; de Leng WW; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.; Broeks A; Core Facility Molecular Pathology & Biobanking, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Labots M; Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.; van Herpen CM; Department of Medical Oncology, Radboud Medical Center, Nijmegen, The Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; Verheul HM; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands.; Snaebjornsson P; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Faculty of Medicine, University of Iceland, Reykjavik, Iceland.; Voest EE; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.

Publisher: John Wiley And Sons Country of Publication: England NLM ID: 0204634 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-9896 (Electronic) Linking ISSN: 00223417 NLM ISO Abbreviation: J Pathol Subsets: MEDLINE

Haj Mohammad SF; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands; Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands. s.f.haj_mohammad@lumc.nl.; Timmer HJL; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands; Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Zeverijn LJ; Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Geurts BS; Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Spiekman IAC; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Verkerk K; Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Verbeek FAJ; Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Verheul HMW; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Voest EE; Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.

Publisher: Medical Journals Sweden AB Country of Publication: Sweden NLM ID: 8709065 Publication Model: Electronic Cited Medium: Internet ISSN: 1651-226X (Electronic) Linking ISSN: 0284186X NLM ISO Abbreviation: Acta Oncol Subsets: MEDLINE

Spiekman IAC; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, The Netherlands.; Geurts BS; Oncode Institute, Utrecht, The Netherlands.; Department of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Zeverijn LJ; Oncode Institute, Utrecht, The Netherlands.; Department of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; de Wit GF; Oncode Institute, Utrecht, The Netherlands.; Department of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; van der Noort V; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Roepman P; Hartwig Medical Foundation, Amsterdam, The Netherlands.; de Leng WWJ; Department of Pathology, University Medical Cancer Center Utrecht, Utrecht, The Netherlands.; Jansen AML; Department of Pathology, University Medical Cancer Center Utrecht, Utrecht, The Netherlands.; Kusters B; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.; Beerepoot LV; Department of Internal Medicine, ETZ Hospital (Elisabeth-TweeSteden Ziekenhuis), Tilburg, The Netherlands.; de Vos FYFL; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.; de Groot DA; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands.; de Groot JWB; Isala Oncology Center, Isala, Zwolle, The Netherlands.; Hoeben A; Division of Medical Oncology, Department of Internal Medicine, GROW School of Oncology and Development Biology, Maastricht University Center+, Maastricht, The Netherlands.; Buter J; Department of Medical Oncology, Amsterdam University Medical Center, Location VuMC, Amsterdam, The Netherlands.; Gelderblom HAJ; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; Voest EE; Oncode Institute, Utrecht, The Netherlands.; Department of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Center for Personalized Cancer Treatment, Rotterdam,The Netherlands.; Verheul HMW; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, The Netherlands.

Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

Zeverijn LJ; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Looze EJ; Division of Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Thavaneswaran S; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, New South Wales, Australia.; St. Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, New South Wales, Australia.; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.; van Berge Henegouwen JM; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; Simes RJ; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.; Hoes LR; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Sjoquist KM; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.; van der Wijngaart H; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Sebastian L; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.; Geurts BS; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Lee CK; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.; de Wit GF; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Espinoza D; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.; Roepman P; Hartwig Medical Foundation, Amsterdam, The Netherlands.; Lin FP; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, New South Wales, Australia.; St. Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, New South Wales, Australia.; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.; Jansen AML; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.; de Leng WWJ; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.; van der Noort V; Biometrics Department, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Leek LVM; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; de Vos FYFL; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.; van Herpen CML; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; Verheul HMW; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands.; Thomas DM; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, New South Wales, Australia.; St. Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, New South Wales, Australia.; Voest EE; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.

Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE

Schutte T; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Medical Oncology, de Boelelaan, Amsterdam, The Netherlands.; Zeverijn LJ; The Netherlands Cancer Institute, Division of Molecular Oncology and Immunology, CX Amsterdam, The Netherlands.; Geurts BS; The Netherlands Cancer Institute, Division of Molecular Oncology and Immunology, CX Amsterdam, The Netherlands.; de Wit GF; The Netherlands Cancer Institute, Division of Molecular Oncology and Immunology, CX Amsterdam, The Netherlands.; Kok M; The Netherlands Cancer Institute, Department of Medical Oncology, CX Amsterdam, The Netherlands.; Opdam FL; The Netherlands Cancer Institute, Department of Medical Oncology, CX Amsterdam, The Netherlands.

Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

Verkerk K; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Oncode Institute, Utrecht, The Netherlands.; Zeverijn LJ; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Oncode Institute, Utrecht, The Netherlands.; van de Haar J; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Oncode Institute, Utrecht, The Netherlands.; Roepman P; Hartwig Medical Foundation, Amsterdam, The Netherlands.; Geurts BS; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Oncode Institute, Utrecht, The Netherlands.; Spiekman AC; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands.; van der Noort V; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, The Netherlands.; van Berge Henegouwen JM; Oncode Institute, Utrecht, The Netherlands; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; Hoes LR; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Oncode Institute, Utrecht, The Netherlands.; van der Wijngaart H; Department of Medical Oncology, GROW, Maastricht University Medical Centre, Maastricht, The Netherlands.; Jansen AML; Department of Pathology, University Medical Cancer Center Utrecht, Utrecht, The Netherlands.; de Leng WWJ; Department of Pathology, University Medical Cancer Center Utrecht, Utrecht, The Netherlands.; Gelderblom AJ; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; Verheul HMW; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands.; Voest EE; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Oncode Institute, Utrecht, The Netherlands. Electronic address: e.voest@nki.nl.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Verkerk K; Department of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; van der Wel TJWT; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Zeverijn LJ; Department of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Geurts BS; Department of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Spiekman IAC; Oncode Institute, Utrecht, the Netherlands.; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands.; de Wit GF; Department of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Roepman P; Hartwig Medical Foundation, Amsterdam, the Netherlands.; Jansen AML; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.; van der Noort V; Biometrics Department, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Smit EF; Department of Pulmonology, Leiden University Medical Center, Leiden, the Netherlands.; Hoeben A; Division of Medical Oncology, Department of Internal Medicine, GROW School of Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands.; Hendriks LEL; Department of Pulmonology, GROW - School for Oncology and Reproduction, Maastricht University Medical Center, Maastricht, the Netherlands.; van den Heuvel MM; Department of Pulmonary Diseases, Radboud University Medical Center, Nijmegen, the Netherlands.; Piet B; Department of Pulmonary Diseases, Radboud University Medical Center, Nijmegen, the Netherlands.; Herder GJM; Department of Pulmonology, Meander Medical Center, Amersfoort, the Netherlands.; Hashemi SMS; Department of Pulmonary Medicine, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; Verheul HMW; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands.; Voest EE; Department of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Center for Personalized Cancer Treatment, the Netherlands.; de Langen AJ; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Geurts BS; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Battaglia TW; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; van Berge Henegouwen JM; Oncode Institute, Utrecht, the Netherlands.; Department of Medical Oncology, Leiden University Medical Centre, Leiden, the Netherlands.; Zeverijn LJ; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; de Wit GF; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Hoes LR; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; van der Wijngaart H; Oncode Institute, Utrecht, the Netherlands.; Department of Medical Oncology, Amsterdam University Medical Centre, location VUMC, Amsterdam, the Netherlands.; van der Noort V; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Roepman P; Hartwig Medical Foundation, Amsterdam, the Netherlands.; de Leng WWJ; Department of Pathology, University Medical Cancer Centre Utrecht, Utrecht, the Netherlands.; Jansen AML; Department of Pathology, University Medical Cancer Centre Utrecht, Utrecht, the Netherlands.; Opdam FL; Department of Clinical Pharmacology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.; de Jonge MJA; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Cirkel GA; Department of Medical Oncology, Meander, Amersfoort, the Netherlands.; Labots M; Department of Medical Oncology, Amsterdam University Medical Centre, location VUMC, Amsterdam, the Netherlands.; Hoeben A; Department of Medical Oncology, Department of Internal Medicine, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands.; Kerver ED; Department of Medical Oncology, Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands.; Bins AD; Department of Medical Oncology, Amsterdam University Medical Centre, location AUMC, Amsterdam, the Netherlands.; Erdkamp FGL; Department of Medical Oncology, Zuyderland Hospital, Sittard-Geelen, the Netherlands.; van Rooijen JM; Department of Medical Oncology, Martini Hospital, Groningen, the Netherlands.; Houtsma D; Department of Medical Oncology, Haga Hospital, The Hague, the Netherlands.; Hendriks MP; Department of Medical Oncology, Northwest Clinics, Alkmaar, the Netherlands.; de Groot JB; Department of Medical Oncology, Isala, Zwolle, the Netherlands.; Verheul HMW; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Centre, Leiden, the Netherlands.; Voest EE; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands. e.voest@nki.nl.; Oncode Institute, Utrecht, the Netherlands. e.voest@nki.nl.

Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Zeverijn LJ; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Geurts BS; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Battaglia TW; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands.; van Berge Henegouwen JM; Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, the Netherlands.; de Wit GF; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Hoes LR; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; van der Wijngaart H; Department of Medical Oncology, Department of Internal Medicine, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands.; van der Noort V; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Roepman P; Hartwig Medical Foundation, Amsterdam, the Netherlands.; de Leng WWJ; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.; Jansen AML; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.; Chalabi M; Department of Gastrointestinal Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; van Herpen CML; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Devriese LA; Division Beeld & Oncologie, Department of Medical Oncology, Utrecht University Medical Center, Utrecht, the Netherlands.; Erdkamp FLG; Department of Medical Oncology, Zuyderland Hospital, Sittard-Geleen, the Netherlands.; Labots M; Department of Medical Oncology, Amsterdam University Medical Center, location VUMC, Cancer Center Amsterdam, Amsterdam, the Netherlands.; de Jonge MJA; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands.; Kerver ED; Department of Medical Oncology, OLVG, Amsterdam, the Netherlands.; Bins AD; Department of Medical Oncology, Amsterdam University Medical Center, location VUMC, Cancer Center Amsterdam, Amsterdam, the Netherlands.; Leek LVM; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Notohardjo JCL; Department of Medical Oncology, Amsterdam University Medical Center, location VUMC, Cancer Center Amsterdam, Amsterdam, the Netherlands.; van den Eertwegh AJM; Department of Medical Oncology, Amsterdam University Medical Center, location VUMC, Cancer Center Amsterdam, Amsterdam, the Netherlands.; Wessels LFA; Oncode Institute, Utrecht, the Netherlands.; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Verheul HMW; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; van de Haar J; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Voest EE; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Center for Personalized Cancer Treatment, Rotterdam, the Netherlands.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Geurts BS; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Zeverijn LJ; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Leek LVM; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; van Berge Henegouwen JM; Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, the Netherlands.; Hoes LR; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; van der Wijngaart H; Department of Medical Oncology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands.; Department of Internal Medicine, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands.; van der Noort V; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands.; van de Haar J; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; van Ommen-Nijhof A; Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.; Kok M; Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.; Roepman P; Hartwig Medical Foundation, Amsterdam, the Netherlands.; Jansen AML; Department of Pathology, University Medical Cancer Center Utrecht, Utrecht, the Netherlands.; de Leng WWJ; Department of Pathology, University Medical Cancer Center Utrecht, Utrecht, the Netherlands.; de Jonge MJA; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands.; Hoeben A; Department of Medical Oncology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands.; Department of Internal Medicine, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands.; van Herpen CML; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Westgeest HM; Department of Internal Medicine, Amphia Hospital, Breda, the Netherlands.; Wessels LFA; Oncode Institute, Utrecht, the Netherlands.; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Verheul HMW; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; Voest EE; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

van Berge Henegouwen JM; Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, the Netherlands.; Zeverijn LJ; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, the Netherlands.; Geurts BS; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, the Netherlands.; Hoes LR; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, the Netherlands.; van der Wijngaart H; Department of Medical Oncology, Maastricht University Medical Center, Maastricht, the Netherlands.; van der Noort V; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Huitema ADR; Department of Pharmacy and Pharmacology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, the Netherlands.; de Vos FYF; Department of Medical Oncology, Utrecht University Medical Center, Utrecht, the Netherlands.; Grünberg K; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands.; Bloemendal HJ; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Verheul HMW; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands.; Voest EE; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, the Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

van Berge Henegouwen JM; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; van der Wijngaart H; Department of Medical Oncology, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Zeverijn LJ; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Hoes LR; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Meertens M; Department of Pharmacy and Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Huitema ADR; Department of Pharmacy and Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pharmacology, Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands.; Devriese LA; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.; Labots M; Department of Medical Oncology, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Verheul HMW; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Voest EE; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands. A.J.Gelderblom@lumc.nl.

Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE

Spiekman IAC; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands.; Zeverijn LJ; Oncode Institute, Utrecht, the Netherlands; Department of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Geurts BS; Oncode Institute, Utrecht, the Netherlands; Department of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Verkerk K; Oncode Institute, Utrecht, the Netherlands; Department of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Haj Mohammad SF; Department of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; van der Noort V; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Roepman P; Hartwig Medical Foundation, Amsterdam, the Netherlands.; de Leng WWJ; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.; Jansen AML; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.; Gootjes EC; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; de Groot DA; Department of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands.; Kerver ED; Department of Medical Oncology, OLVG, Amsterdam, the Netherlands.; van Voorthuizen T; Department of Medical Oncology, Rijnstate, Arnhem, the Netherlands.; Roodhart JML; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, the Netherlands.; Valkenburg-van Iersel LBJ; Division of Medical Oncology, Department of Internal Medicine, GROW school of Oncology and Development Biology, Maastricht University Center+, Maastricht, the Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; Voest EE; Oncode Institute, Utrecht, the Netherlands; Department of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Verheul HMW; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands. Electronic address: h.verheul@erasmusmc.nl.

Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Battaglia TW; Division of Molecular Oncology & Immunology, the Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands; Division of Molecular Carcinogenesis, the Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands; Oncode Institute, the Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands.; Mimpen IL; Division of Molecular Oncology & Immunology, the Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands; Oncode Institute, the Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands.; Traets JJH; Division of Tumor Biology & Immunology, the Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands.; van Hoeck A; Oncode Institute, the Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands; Department of Head and Neck Surgery and Oncology, the Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.; Zeverijn LJ; Division of Molecular Oncology & Immunology, the Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands; Oncode Institute, the Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands.; Geurts BS; Division of Molecular Oncology & Immunology, the Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands; Oncode Institute, the Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands.; de Wit GF; Division of Molecular Oncology & Immunology, the Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands; Oncode Institute, the Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands.; Noë M; Department of Pathology, Antoni van Leeuwenhoek/the Netherlands Cancer Institute, Amsterdam, the Netherlands.; Hofland I; Core Facility Molecular Pathology & Biobanking, the Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands.; Vos JL; Division of Tumor Biology & Immunology, the Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands; Head and Neck Service and Immunogenomic Oncology Platform, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Cornelissen S; Core Facility Molecular Pathology & Biobanking, the Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands.; Alkemade M; Core Facility Molecular Pathology & Biobanking, the Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands.; Broeks A; Core Facility Molecular Pathology & Biobanking, the Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands.; Zuur CL; Division of Tumor Biology & Immunology, the Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands; Department of Head and Neck Surgery and Oncology, the Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Department of Otorhinolaryngology Head and Neck Surgery, Leiden University Medical Center, Leiden, the Netherlands.; Cuppen E; Center for Molecular Medicine, University Medical Centre Utrecht, Utrecht 3584CX, the Netherlands; Hartwig Medical Foundation, Science Park, Amsterdam 1098XH, the Netherlands.; Wessels L; Division of Molecular Carcinogenesis, the Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands; Oncode Institute, the Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands; Faculty of EEMCS, Delft University of Technology, Delft 2628 CD, the Netherlands.; van de Haar J; Division of Molecular Oncology & Immunology, the Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands; Oncode Institute, the Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands.; Voest E; Division of Molecular Oncology & Immunology, the Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands; Oncode Institute, the Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands. Electronic address: e.voest@nki.nl.

Publisher: Cell Press Country of Publication: United States NLM ID: 0413066 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4172 (Electronic) Linking ISSN: 00928674 NLM ISO Abbreviation: Cell Subsets: MEDLINE

Verkerk K; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Geurts BS; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Zeverijn LJ; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; van der Noort V; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Verheul HMW; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands.; Haanen JBAG; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Clinical Oncology, LUMC, Leiden, the Netherlands.; Head of Melanoma Clinic, CHUV, Lausanne, Switzerland.; van der Veldt AAM; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands.; Department of Radiology & Nuclear Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.; Eskens FALM; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands.; Aarts MJB; Department of Medical Oncology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands.; van Herpen CML; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Jalving M; Department of Medical Oncology, University of Medical Center Groningen, Groningen, the Netherlands.; Gietema JA; Department of Medical Oncology, University of Medical Center Groningen, Groningen, the Netherlands.; Devriese LA; Department of Medical Oncology, Division Beeld & Oncologie, Utrecht University Medical Center, Utrecht, the Netherlands.; Labots M; Department of Medical Oncology, Amsterdam University Medical Center, Location VUMC, Cancer Center Amsterdam, the Netherlands.; Barjesteh van Waalwijk van Doorn-Khosrovani S; CZ Health Insurance, Tilburg, the Netherlands.; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; Smit EF; Department of Pulmonology, Leiden University Medical Center, Leiden, the Netherlands.; Bloemendal HJ; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.

Publisher: [Oxford] Country of Publication: England NLM ID: 101777707 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-7762 (Electronic) Linking ISSN: 26667762 NLM ISO Abbreviation: Lancet Reg Health Eur Subsets: PubMed not MEDLINE

Bokslag A; Department of Obstetrics and Gynaecology, Amsterdam UMC, Vrije Universiteit Amsterdam , Amsterdam, The Netherlands.; Fons AB; Department of Obstetrics and Gynaecology, Amsterdam UMC, Vrije Universiteit Amsterdam , Amsterdam, The Netherlands.; Zeverijn LJ; Department of Obstetrics and Gynaecology, Amsterdam UMC, Vrije Universiteit Amsterdam , Amsterdam, The Netherlands.; Teunissen PW; Department of Obstetrics and Gynaecology, Amsterdam UMC, Vrije Universiteit Amsterdam , Amsterdam, The Netherlands.; School of Health Professions Education (SHE), Maastricht University , Maastricht, The Netherlands.; de Groot CJM; Department of Obstetrics and Gynaecology, Amsterdam UMC, Vrije Universiteit Amsterdam , Amsterdam, The Netherlands.

Publisher: Informa Healthcare Country of Publication: England NLM ID: 9421297 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-6065 (Electronic) Linking ISSN: 10641955 NLM ISO Abbreviation: Hypertens Pregnancy Subsets: MEDLINE